For these studies, we used A549 and H460 NSCLC cells, well-established cellular models of lung cancer carrying oncogenic K-Ras mutations at residues G12 (A549) and Q61 (H460), which are commonly found in human lung cancer. The gene discussed is KRAS; the disease is lung cancer.